Associated Papers
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.
Iancu O et al.
Molecular Therapy. Nucleic Acids, 2023
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Dobbs K et al.
Frontiers in Immunology, 2017
The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
Lev A et al.
Plos One, 2012
Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes.
Lev A et al.
Clinical & Developmental Immunology, 2012
Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.
Dalal I et al.
Clinical Immunology (orlando, Fla.), 2011
Select a paper to view details